Liaoning Cheng Da Co., Ltd. (SHA:600739)

Market Cap	16.23B -16.3%
Revenue (ttm)	9.43B -12.4%
Net Income	940.13M +100.4%
EPS	0.62 +100.4%
Shares Out	1.52B
PE Ratio	17.26
Forward PE	n/a
Dividend	0.15 (1.41%)
Ex-Dividend Date	Aug 13, 2026

Volume	23,755,396
Open	10.92
Previous Close	10.96
Day's Range	10.60 - 10.93
52-Week Range	9.84 - 13.58
Beta	0.67
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 31, 2026

About Liaoning Cheng Da

Liaoning Cheng Da Co., Ltd. engages in pharmaceuticals and healthcare, financial investment, trading, and energy development businesses in China and internationally. The company is involved in the import and export of textiles, and clothing, as well as the trade of bulk commodities, such as coal, steel, and aquatic products; and oil shale mining, shale oil production, and sale business. It also offers financial service enterprises including securities, insurance, and funds; human rabies vaccines and inactivated Japanese encephalitis vaccines; m...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1991
• Employees: 2,740
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600739

Financial Performance

In 2025, Liaoning Cheng Da's revenue was 9.90 billion, a decrease of -8.06% compared to the previous year's 10.77 billion. Earnings were 736.55 million, an increase of 251.48%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 21, 2026

Data Sources Report a data error